To be or not to be? Daily oral versus long-acting injectable medicines for HIV prevention BY SHOBHA SHUKLA – CNS To be or not to be? Daily oral versus long-acting injectable medicines for HIV ...

Some had lost friends or lovers. Some felt a moral calling. Some were just trying to balance their sexual karma. Many were angry. Most had no medical background or professional credentials – just a ...

As Houston battles a surge in HIV and STI rates, the federal funding that supports free testing and prevention services is ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...

HIV response. Experts are suggesting a projected 24% decrease in HIV funding over the next year in the context of reductions ...

Research keeps you on the forefront and provides opportunities for patients and staff. It’s the only way we’ll ever move ...

Who is being left behind? – herald Tawanda Musarurwa Check Point Desk “EVEN when people know about HIV and take risks, there are still many reasons why some men might not go for testing. “Sometimes it ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Donald Trump's cuts to HIV/AIDS programmes will further derail an already faltering plan to end the disease as a public ...

The timing of the reduction has stunned health officials, who say Kenya should be increasing, not decreasing, domestic ...

In the wake of U.S. aid cuts, Pastor Billy is reminded of his twin sister's death from AIDS. He doesn't want 9-year-old Diana ...